14:55:18 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-08 Kvartalsrapport 2024-Q3
2024-08-23 Kvartalsrapport 2024-Q2
2024-05-14 Kvartalsrapport 2024-Q1
2024-04-29 Ordinarie utdelning OMDA 0.48 NOK
2024-04-25 Årsstämma 2024
2024-03-01 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-09-26 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-12 Kvartalsrapport 2023-Q1
2023-04-28 Ordinarie utdelning OMDA 0.00 NOK
2023-04-27 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-30 Kvartalsrapport 2022-Q3
2022-10-03 Extra Bolagsstämma 2022
2022-08-30 Kvartalsrapport 2022-Q2
2022-05-20 Ordinarie utdelning OMDA 0.00 NOK
2022-05-19 Kvartalsrapport 2022-Q1
2022-05-19 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-05-07 Ordinarie utdelning OMDA 0.00 NOK
2021-05-06 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-12-11 Extra Bolagsstämma 2020
2020-11-27 Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.
2023-01-30 18:42:57
Please see below information about transactions made under the share buy-back
programme for CSAM Health Group AS ("CSAM" or the "Company") (Ticker: CSAM NO).

Date on which the share buy-back programme was announced: 30 November 2022.

The duration of the buy-back programme: 20 January 2023 until and including the
day before the Company's Annual General Meeting in 2023.

Size of the buy-back programme: Up to 666,666 shares, for a maximum
consideration of NOK 20,000,000.
From 20 January 2023 until 30 January 2023 CSAM has purchased a total of 5,610
own shares at an average price of 38,6604 per share.

Aggregated overview of transactions per day:


Date Aggregate daily volume(#of shares)Weighted average price(NOK)Total
transaction value(NOK)
20 January 2023 1,451 39.4429 57,231.65
23 January 2023 913 38.1788 34,857.24
24 January 2023 0 n.a. n.a.
25 January 2023 1,402 37.7401 52,911.62
26 January 2023 1,734 39.1080 67,813.27
27 January 2023 0 n.a. n.a.
30 January 2023 110 37.0082 4,070.90

Previously disclosed buy-backs under the programme (aggregate):
n.a. n.a. n.a.
Total purchased under the programme:
5,610 38.6604 216,884.69


This information is published in accordance with the requirements in article 5
of the EU Market Abuse Regulation and subject to the disclosure requirements
pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back
programme that have been carried out during the above-mentioned time period is
attached to this report.

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@csamhealth.com

About CSAM
CSAM Health Group is the leading provider of specialised software for healthcare
in the Nordics. From this solid foundation the company has grown to serve more
than 500 customers in 27 countries. Our highly specialised software solutions
are instrumental in the clinical care processes of healthcare providers and in
enabling emergency responders to enhance public safety. CSAM's headquarters are
in Oslo, Norway. CSAM has more than 300 dedicated specialists in ten countries
across Europe, Asia, Oceania and North America, including a wholly owned
software engineering subsidiary in the Philippines.


For more information, visit www.csamhealth.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH